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Abstract: X-ray radiotherapy is a common method of treating cancerous tumors or other malignant
lesions. The side effects of this treatment, however, can be deleterious to patient quality of life
if critical tissues are affected. To potentially lower the effective doses of radiation and negative
side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species
production during irradiation. This report presents the synthesis and radiotherapeutic efficacy
evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF2 core,
mesoporous silica shell, and polyethylene glycol coating. The construct was additionally doped with
Tb and Eu during the CaF2 core synthesis to prepare nanoparticles (NPs) with X-ray luminescent
properties for potential application in fluorescence imaging. The mesoporous silica shell was added
to provide the opportunity for small molecule loading, and the polyethylene glycol coating was
added to impart aqueous solubility and biocompatibility. The potential of these nanomaterials to
act as radiosensitizers for enhancing X-ray radiotherapy was supported by reactive oxygen species
generation assays. Further, in vitro experiments indicate biocompatibility and enhanced cellular
damage during X-ray radiotherapy.
Keywords: CaF2; mesoporous silica; nanoparticle; core-shell; lanthanide-doped; polyethylene glycol;
hydrothermal annealing; radioluminescence; radiotherapy
1. Introduction
X-ray radiation plays a key role in various diagnostic and treatment modalities in modern medicine.
In part, the high photon energy of X-rays allows for greater tissue penetration depth compared to lower
energy photons. As such, new diagnosis and treatment modalities are being developed using X-ray
responsive materials [1–3]. Upon irradiation, radiation responsive materials absorb energy from X-rays
through various interactions, which results in the production of lower energy photons in secondary
processes that can subsequently cause specific chemical reactions or radioluminescence (RL) [4–6].
The observation of these material-specific X-ray activated characteristics has resulted in numerous
studies into the synthesis and application of materials for cancer-based theranostics.
X-ray radiotherapy (XRT) is a common treatment modality for cancerous tumors which is often
delivered in the form of external beam radiation. In addition to direct cellular damage, radiation
therapy works indirectly by generating chemically reactive small molecules and molecular radicals,
Nanomaterials 2020, 10, 1447; doi:10.3390/nano10081447 www.mdpi.com/journal/nanomaterials
Nanomaterials 2020, 10, 1447 2 of 18
largely through radiolysis of water. These reactive species subsequently react with critical cellular
components (e.g., DNA), thus decreasing survival and cellular replication. However, as XRT damages
everything within the path of the radiation, including healthy tissue, radiosensitizers have been studied
as a means of selectively multiplying local cellular damage in cancerous tissues during XRT [2].
Inorganic nanoparticles (NPs) have shown promise as radiosensitizers due to their high structural
density and composition variability. Compared to bodily tissues, denser, higher atomic number
nanomaterials have higher probability interactions with X-rays, and thus better X-ray attenuation is
expected. These interactions include X-ray absorption and scattering by inorganic NPs, accompanied
by deposition of energy from the incident photons within the local microenvironment surrounding
the NPs [4,5]. A critical consequence of this energy deposition is increased generation of reactive
oxygen species (ROS), as well as a variety of additional chemically reactive species (e.g., molecular
radicals), leading to damage of the surrounding cellular structures [7]. The capability of NPs for this
type of enhancement was initially demonstrated by Hainfeld et al. in 2004, using Au NPs to sensitize
XRT [8]. Whether relying on physical enhancement by dense materials that strongly attenuate X-rays,
or directing energy from X-ray photons to specific chemical pathways, inorganic NPs have widely
been investigated as radiotherapeutic agents [8–13].
Alongside radiotherapeutic strategies, some inorganic NPs have also been designed for use in
X-ray activated diagnostic imaging. Inorganic NPs that can convert absorbed energy from incident
X-rays into visible photons can enable radioluminescence (RL) imaging, by locating the NPs with
high spatial resolution via their visible-range photon emission [6,14]. Our group and several others
have realized this application in vivo, for example with the use of Ba0.55Y0.3F2:Eu3+ by our group
or Eu-doped NaGdF4 NPs by Sudheendra et al. [15,16]. In these cases, luminescent europium ion
lattice dopants in the nanocrystals exhibited characteristic strong emissions in the visible spectrum,
between 500–700 nm. This wavelength range corresponds well with effective tissue transmission [17].
These properties, along with their strong X-ray interactions, illustrate the potential of luminescent NPs
such as these to act as both diagnostic and therapeutic agents.
Calcium fluoride (CaF2) is a popular optical matrix for designing luminescent materials and has
additional properties that make it useful for RL applications, such as RL-based biomedical imaging.
The photonic and thermal properties of CaF2, such as its large bandgap (12 eV) and low phonon energy,
reduces non-radiative energy loss and increases the probability of radiative decay at the dopant site,
making CaF2 an effective host matrix in the visible to UV range. Further, the similar ionic radius of
Ca2+ to various fluorescent lanthanide ions, as well as the high symmetry of the cation sites in the
face-centered cubic structure of CaF2, makes the inclusion of such dopants straightforward and permits
the symmetries of their excited states [18,19]. Additionally, CaF2 has a density of 3.18 g/cm3 and a
higher average atomic number than most biological tissues, properties that increase the probability of
X-ray interactions. Correspondingly, a variety of syntheses have been developed to formulate doped
CaF2 NPs for photonics-based applications, including those in the biomedical field [20–23]. Typical
syntheses of CaF2 NPs are performed using coprecipitation procedures in either water or short-chain
alcohols [24–27]. However, while the large lattice enthalpy of CaF2 makes coprecipitation highly
thermodynamically accessible, the relatively fast reaction rate limits overall reaction control.
In this work, CaF2 and Ln-doped CaF2 NPs (Ln = Eu or Tb) were synthesized using an aqueous
coprecipitation method followed by hydrothermal annealing. This method capitalizes on the synthetic
ease of coprecipitation methods, ease of lanthanide ion doping, and the ability to access larger
single-crystal NP sizes through hydrothermal annealing [27,28]. While many syntheses of CaF2 NPs
employ a hydrothermal annealing step, this work correlates the effect of annealing over time to changes
in the Ln-doped CaF2 NPs crystallite size and luminescence emission intensity, intending to increase
radioluminescence quantum yield. Results suggest that the fusion of grain boundaries occurs rapidly,
improving quantum yield, while the annealing of defect sites within the crystallites occurs at a slower
rate and is also critical for improving the quantum yield. After improving the luminescence of the NPs,
they were then coated with a mesoporous silica (MS) shell, followed by covalently bound polyethylene
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glycol-silane (PEG-silane). The NP products are thoroughly characterized through the synthetic steps
leading to the overall CaF2:Ln-MS-PEG NP constructs, using transmission electron microscopy (TEM),
X-ray diffraction (XRD), energy-dispersive X-ray spectroscopy (EDX), Fourier transform infrared
spectroscopy (FT-IR), dynamic light scattering (DLS), and radioluminescence (RL).
Further, we demonstrate in vitro that the strongly radioluminescent MS:Ln-CaF2 NPs are highly
biocompatible in the absence of X-rays, while decreasing the viability of CT26 colorectal cancer cells
under XRT conditions. Thus, the novel CaF2:Ln-MS-NP constructs synthesized and reported herein are
promising for further study as a combined radiotherapeutic and radiodiagnostic in XRT and RL-guided
spatial imaging applications.
2. Materials and Methods
2.1. Materials
The following chemicals were purchased and used without purification: For CaF2 synthesis:
CaCl2 (99%, anhydrous, Acros, Geel, Belgium), TbCl3·6H2O (99%, Acros, Geel, Belgium), EuCl3·6H2O
(99%, Sigma Aldrich, St. Louis, MO, USA), Sodium citrate dihydrate (99%, J.T. Baker, Phillipsburg, NJ,
USA), Ammonium fluoride (98%, Sigma-Aldrich, St. Louis, MO, USA), ethanol (95%, Thermo-Fisher,
Waltham, MA, USA). For Mesoporous silica coating: Cetyltrimethyl ammonium bromide (99%,
Research Organics, Cleveland, OH, USA), ethanol (200 proof, Decon Labs, King of Prussia, PA, USA),
tetraethoxysilane (98%, Sigma-Aldrich, St. Louis, MO, USA), triethylamine (99%, Acros, Geel, Belgium),
2-[methoxy(polyethyleneoxy)9-12propyl]trimethoxysilane (tech grade, 70+%, Gelest, Morrisville, PA,
USA). For ROS quantification assays: aminophenyl fluorescein (APF, 99%, Thermo-Fisher, Waltham,
MA, USA), Singlet Oxygen Sensor Green (SOSG, 99%, Thermo-fisher, Waltham, MA, USA) (All reagents
in all experiments used as received).
2.2. CaF2 and Ln-Doped CaF2 Nanoparticle Syntheses
Scheme 1 outlines the following procedures including CaF2 NP synthesis and mesoporous silica
coating. In a typical synthesis, a 50 mL round bottom flask was loaded with calcium chloride, or calcium
and lanthanide chlorides (Tb or Eu). The reagent masses used are detailed in Table 1 and were chosen
to target nanomaterials with ~20 atomic percent Ln dopant in place of Ca ions.
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Table 1. Metal chloride masses added to flasks to attain certain doping amounts.
Synthesis Target (Dopants in Atomic %) Calcium Chloride Mass (mg) Doping Metal Chloride Mass (mg)
Undoped CaF2 NPs 388 None
CaF2:Tb 18% NPs 350 93 TbCl3·6H2O
CaF2:Eu 18% NPs 350 90 EuCl3·6H2O
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Along with the metal chlorides, 5.17 g of sodium citrate dihydrate was added, followed by 22 mL
of distilled water. This solution was stirred for 10 min at room temperature (25 ◦C) to allow the solids
to dissolve completely. The resulting concentrations in solution were then 126.14 mM CaCl2, 9.96 mM
LnCl3·6H2O, and 0.7 M sodium citrate dihydrate. For undoped CaF2 NPs, the CaCl2 concentration
was 139.84 mM. Meanwhile, 322 mg of ammonium fluoride was dissolved in 5 mL of distilled water
(1.74 M) in a 15 mL centrifuge tube. This solution was loaded into a burette. Then, while still under
continuous stirring, ammonium fluoride solution was added dropwise into the round bottom flask
containing the metal chloride solution, at a rate of approximately one drop per second. After all the
fluoride solution was added, the slightly turbid solution in the round bottom flask was divided evenly
into three 20 mL Teflon autoclave liners, which were placed in stainless steel autoclaves (Parr, Moline,
IL, USA) and rapidly heated to a temperature of 180 ◦C for 6 h. Following heating, the autoclaves
were subsequently cooled to room temperature, and the product solutions in the three autoclaves were
collected together into a 50 mL centrifuge tube. Then, 10 mL of ethanol (95%) was added, and the
product suspensions were centrifuged to isolate the NPs. The NPs were again redispersed in a solution
of 5 mL of water and 35 mL of ethanol, followed by centrifugation. This process was repeated until
the dark carbonized species left over from the reaction were no longer present. Finally, the CaF2 (or
CaF2:Ln) NPs were dried overnight at 50 ◦C, then crushed to a fine powder using a mortar and pestle
and stored for further use.
2.3. Mesoporous Silica Coating
Into a 250 mL round bottom flask were added 54 mg of dried, powdered CaF2 NPs, and 100 mL
of distilled water, followed by sonication for 30 min. Then, 10 mL of ethanol (200 proof), 84 µL of
triethylamine (to attain a concentration of 5.48 µM), and 1.8 g of cetyltrimethyl ammonium bromide
(CTAB) (44.9 mM) were added to the flask. The reaction mixture was next heated to 80 ◦C and
stirred at 1400 rpm with a 3 cm almond-shaped stir bar, which resulted in the formation of CTAB
micelles. Next, 300 µL of tetraethoxysilane (TEOS) (12.3 mM) was added to the flask dropwise over 20 s.
The flask was subsequently heated and stirred for an additional 30 min to accomplish the hydrolysis
and polycondensation of the TEOS around the CTAB, followed by cooling in a stirring water bath
for 60 s. The reaction products were then collected in centrifuge tubes, followed by centrifugation
to isolate the silica-coated CaF2 NP products. The silica-coated CaF2 NPs were next resuspended
in 20 mL of ethanol (200 proof), followed by 10 min of sonication. This colloidal suspension was
subsequently transferred to a 100 mL round bottom flask, and then 2 mL of 12 M hydrochloric acid
was added to remove the CTAB within the silica network and render the silica coating mesoporous
(MS = mesoporous SiO2). The resulting colloidal suspension containing the MS-CaF2 NPs was stirred
and heated to 80 ◦C for 30 min. Then it was cooled in a stirring water bath, and solids were collected
by centrifugation. The isolated MS-CaF2 NPs were purified two cycles of redispersion in a 1 mL water
and 20 mL ethanol solution, followed by centrifugation. Finally, the MS-CaF2 NPs were dried at 50 ◦C,
milled to a powder in a mortar and pestle, and stored for further use.
2.4. Surface Modification by Covalent Attachment of Polyethylene Glycol
15 mg of MS-CaF2 NPs were suspended in 20 mL of distilled water in a 100 mL round bottom flask,
followed by sonication. While stirring at room temperature, 40 µL of ammonium hydroxide (30% w/w
in water) was added, followed by 100 µL of 2-[methoxy(polyethyleneoxy)9-12propyl]trimethoxysilane
(PEG-silane). After PEG-silane addition, the reaction mixture was left stirring at room temperature for
two hours. At the end of this time, the reaction products were poured into a centrifuge tube, and 10 mL
of ethanol was added to flocculate the pegylated MS-CaF2 NPs (PEG-MS-CaF2 NPs). The PEG-MS-CaF2
NPs were collected by centrifugation, followed by resuspension in 10 mL of 1:1 water: ethanol and
centrifuging, and additional purification by 2 more cycles of redispersion and centrifuging with 10 mL
of ethanol. Finally, the PEG-MS-CaF2 NP products were dried overnight at 50 ◦C, then crushed to a
fine powder using a mortar and pestle, and stored for further use.
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2.5. Instrumental Analysis
The NP products through the stages of synthesis were characterized using a combination of
transmission electron microscopy (TEM), energy dispersive X-ray spectroscopy (EDX), X-ray diffraction
(XRD), radioluminescent spectroscopy, and x-ray photoelectric spectroscopy (XPS).
Transmission Electron Microscopy was performed on a Tecnai F20 TEM (FEI, Hillsboro, OR, USA)
operating at 4200 eV. Samples were prepared by dispersing NPs in ethanol (ACS) at concentrations of
approximately 1 mg/mL and drop-casting a single drop onto type-B carbon-coated copper TEM grids
(Ted Pella Product #1844-F, Redding, CA, USA). These samples were dried at room temperature for
10 min before drying in a 50 ◦C oven for at least one hour before imaging. The mean diameters of the
nanoparticle samples were determined by analyzing several TEM images, corresponding to different
(representative) areas of each sample grid. ImageJ software (version 1.51n, National Institutes of Health,
Bethesda, MD, USA) was used to measure the NPs and produce size distributions; each reported size
value is based on the minimum requirement to measure at least 200 NPs. To prevent measurement bias,
the minimum criteria for an individual image used in mean diameter determination were that it must
include at least 50 NPs and that all NPs in the image had to be measured. EDX measurements were
taken using the same instrument in scanning-TEM mode and collected using an Oxford Instruments
EDX detector (Abingdon, Oxfordshire, England).
X-ray diffraction patterns were collected using a Rigaku Ultima IV X-ray diffraction system (Tokyo,
Japan) using graphite monochromatized Cu Kα radiation. Samples were prepared by grinding dry
powders in a mortar and pestle and placing them in a glass sample holder. Patterns were collected
with a continuous movement measurement at a resolution of 0.05◦ rate of 1 degree per minute from
20 to 60◦ 2θ. The resulting data was analyzed using Rigaku PDXL2 software. Crystallite size was
estimated using the Scherrer equation (Equation (1)) in which τ is the mean crystallite size, K is the
shape factor which is assumed as a sphere, λ is the X-ray wavelength, β is the peak width at half of the





FT-IR spectra were obtained using a Thermo Scientific Nicolet iS10 spectrometer (Waltham, MA,
USA) fitted with an attenuated total reflectance attachment having a diamond window. Solid samples
were first dried of solvents by heating at 125 ◦C, then placed directly on the diamond window and
compressed. Spectra were averaged from 32 scans, taken at a 1 cm−1 resolution between 650–4000 cm−1.
For the Ln-doped, CaF2 NPs, photoluminescence (PL) spectroscopy was performed using a
Shimadzu RF-5301PC fluorimeter (Canby, OR, USA). The Ln-doped, CaF2 NPs colloidal solutions used
in these measurements were prepared by sonicating the corresponding dry powders in water at a
concentration of 1 mg/mL. X-ray excited luminescence spectra were also acquired, using 30 mg of dry
Ln-doped CaF2 NP powder for each measurement, and a CellRad Faxitron X-ray system (Precision
X-ray Irradiation, North Branford, CT, USA) operating at 130 kV and 5 mA as the excitation source;
no beam filter was applied. The X-ray excited luminescence was recorded using a StellarNet Silver
Nova 200 spectrometer (Tampa, FL, USA) attached to a collimating lens via armored fiber-optic cable
(Thorlabs, Newton, NJ, USA)). These measurements were collected with an integration time of 30 s.
X-ray Photoelectron Spectroscopy (XPS) was performed on a Versaprobe II XPS/AES (ULVAC-PHI,
Chanhassen, MN, USA) featuring an aluminum X-ray source. Samples were prepared for XPS
measurements by drop-casting NP suspensions in methanol onto individual aluminum foil substrates
heated at 50 ◦C, followed by drying the samples under vacuum at room temperature for 12 h before
placement in the XPS transfer arm. Once in the vacuum chamber, the samples were bombarded
with X-rays from the source, in circular spots with diameters of 100 µm. The electron beam used in
these experiments was operating at 125 V and 50 W, and charge balancing was provided by both an
e-neutralizer and argon-derived ion beam. The spectra were calibrated to the carbon 1s peak present
in each spectrum.
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Dynamic light scattering (DLS) was performed using a Malvern Nano ZSP (Malvern Panalytical,
Malvern, UK) to determine the size, zeta potential, and polydispersity. Samples were prepared by
dispersing 100 µg of NPs in 1 mL of millipure water, briefly sonicating, then transferring to a DLS
cuvette with gold-plated contacts for zeta potential measurements.
2.6. ROS Quantification Assays
Stock colloidal solutions of CaF2:Tb-MS-PEG were prepared in water, with fixed concentrations of
1 µg NP per 1 mL of water. Each colloidal solution was sonicated for at least 5 min before it was plated
in the wells of a 96-well plate, each well containing 100 uL of the NP stocks. Some wells contained
only millipure water instead of nanoparticle solutions as a control. Next, either 10 uL of a 10 µM APF
solution or 10 uL 10 µM SOSG solution were added to the sample and control wells. These plates were
transferred to a Faxitron Cellrad X-ray irradiator (Precision X-ray Irradiation, North Branford, CT,
USA) and irradiated at 130 kVp and 20 mA for variable amounts of time to attain different delivered
radiation doses (2,4,6,8,10,12,14 Gy). As the pre-determined dosing conditions were met, triplicates of
wells were removed from the irradiator to a separate 96 well plate in which the solutions would be
analyzed. After all conditions were collected, the 96 well plates were analyzed for photoluminescence
using an Infinite M200 Pro plate reader (Tecan US Inc, Morrisville, NC, USA.) APF fluorescence was
measured using an excitation wavelength of 490 nm, while monitoring emission intensity at 520 nm,
and SOSG fluorescence was measured using an excitation wavelength of 500 nm, while monitoring
emission intensity at 525 nm.
2.7. In Vitro Cell Viability
Murine fibroblast (NIH 3T3) and human liver carcinoma (HepG2) cells (both sourced from
ATCC, Manassas, VA, USA) were cultured in appropriate growth media and seeded at a density of
approximately 10,000 cells per well into a 96-well plate. Cells were allowed to settle and grow for
approximately 24 h prior to dosing, with either media containing CaF2:Tb-MS-PEG NPs, or a control
solution. A dosing plate was prepared at a maximum concentration of 500 µg/mL for CaF2:Tb-MS-PEG
in media. The maximum concentration was then serially diluted by half to prepare lower concentrations
(500, 250, 125, 62, 31, 15, 7.5, 3.7, and 1.9 µg/mL). All dilutions were added to plates in triplicate
(technical replicates) at 100 µL per well for 24 h. Following exposure of the cells to the NP solutions
(or blank media), cell viability was assayed using alamarBlueTM cell viability reagent (10% vol/vol
in media, Thermo-Fisher, Waltham, MA, USA) where the wells were individually irradiated using
an excitation wavelength of 530 nm and emission was monitored at 590 nm with an Infinite M200
Pro plate reader (Tecan US Inc, Morrisville, NC, USA). All results were normalized to untreated cells.
All experiments were performed in triplicate (biological replicates).
2.8. In Vitro XRT
Murine colorectal cancer (CT26) cells (ATCC, Manassas, VA, USA) were grown in the appropriate
media and seeded at a density of approximately 2000 cells in a 96 well plate. Cells were allowed to
settle and grow for approximately 24 h prior to dosing. A dosing plate was prepared at a maximum
concentration of 500 µg/mL for CaF2:Tb-MS-PEG in media. The maximum concentration was then
serially diluted by half to prepare lower concentrations (500, 250, 125, 62, 31, 15, 7.5, 3.7, and 1.9 µg/mL).
Cells were then incubated with the CaF2:Tb-MS-PEG NPs for 24 h, then the media was removed
and replaced prior to 4 Gy radiation at 130 kVp using a Faxitron CellRad irradiator (Precision X-ray
Irradiation, North Branford, CT, USA). Cells were than incubated for an additional 24 h and cell
viability was measured using alamarBlueTM cell viability reagent (Thermo-Fisher, Waltham, MA, USA)
and measured on an Infinite M200 Pro plate reader (Tecan US Inc, Morrisville, NC, USA) at 530 nm
excitation and 590 nm emission. All results were normalized to untreated cells. All experiments were
performed in triplicate (biological replicates).
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3. Results and Discussion
3.1. Synthesis and Impacts of Hydrothermal Annealing on Crystallite Size
Synthesis of CaF2 NPs was achieved by a modified method adapted from Pedroni et al.,
who developed a synthesis to study near-IR to visible photon conversion in NP optical matrices [21].
In this procedure, an aqueous solution containing calcium ions, or calcium and lanthanide ions,
is introduced to a separate solution of fluoride ions within an environment highly concentrated
with citrate. The citrate acts as a steric and electrostatic surface stabilizer. Due to the large lattice
enthalpy that causes calcium and lanthanide ions to precipitate in the presence of fluoride, CaF2 NPs
or Ln-doped CaF2 NPs readily form upon mixing the component ion solutions. The as-prepared NPs
are typically pseudo-spherical and have diameters ranging from 10–20 nm (Figure 1A). Subsequently,
the as-prepared NPs were annealed in a hydrothermal cell for 6 h at 180 ◦C, which resulted in the
formation of highly regular cubic nanocrystals; the overall mean diameter for a representative CaF2
NP sample following annealing is 13.6 ± 3.5 nm (Figure 1B), still within the typical range of sizes
prior to hydrothermal treatment. Estimates of the elemental composition of the CaF2 NPs via EDX
measurements showed particle compositions close to the expected ratio of 1:2 calcium: fluorine in
the undoped CaF2 NPs (Figure S1). In comparison, when 15% of the calcium ions were replaced with
either terbium or europium ions in the metal ion precursor solution, EDX measurements showed that
the Ln ion accounted for approximately 18% of the cations in the resulting CaF2:Ln NPs (Figure S1).
By TEM, it was observed that the ~18% replacement of calcium ions with either terbium or europium
ions did not significantly alter the typical diameters or morphologies of NPs; for example, a typical
sample of CaF2:Tb NPs after hydrothermal annealing (Figure 1C, Table S1) has a mean diameter of
13.4 ± 4.2 nm, and is still somewhat faceted.
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Figure 1. Transmission electron microscopy (TEM) images of: (A) CaF2 nanoparticles (NPs) before 
and (B) after hydrothermal annealing, and (C) Tb-doped CaF2 NPs after hydrothermal annealing. X-
ray diffraction (XRD) patterns of CaF2 NPs (D) before and (E) after hydrothermal annealing, and (F) 
Eu-doped and (G) Tb-doped CaF2 NPs. 
2 rticles )
( ) after hydrothermal a nealing, and (C) Tb-doped CaF2 NPs after hydrothermal annealing.
X-ray diffraction (XRD) patterns of CaF2 NPs (D) before and (E) after hydrothermal annealing, and (F)
s.
While hydrothermal annealing did not substantively alter the TEM-observable mean diameters
of the NPs, changes in the crystallite size were observable by PXRD. PXRD patterns before and after
hydrothermal treatment (Figure 1D,E) both reveal the expected diffraction pattern of the fluorite-type
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CaF2 lattice; all peaks can be indexed to fluorite CaF2 (PDF Card 35816), and there are no obvious
crystalline impurities. Noticeable peak broadening is observed both before and after hydrothermal
treatment, and the FWHM of the peaks can be used to estimate the crystallite size using the Scherrer
equation. Before hydrothermal annealing, the NPs have a calculated mean diameter of 3.2 ± 1.8 nm,
which increases to 10.2 ± 1.6 nm following annealing. The similarity between the PXRD-determined
crystallite size and the TEM-measured diameter of the NPs post-annealing indicates that the annealed
NPs are single crystalline, whereas they were likely polycrystalline prior to the treatment [29,30]. It is,
therefore, reasonable to conclude that the annealing treatment reduces grain boundaries within the
as-prepared NPs, more so than it results in the ripening of the as-prepared NPs into larger particles.
Finally, in comparison of the PXRD patterns of Ln-doped vs. undoped CaF2 NPs following
annealing, it was observed that both the peak positions and the crystallite sizes are essentially the
same at the ~18% level of Ln doping (Figure 1F,G); that is, the addition of Ln-dopant does not result in
substantive structural or size changes in the product NPs.
3.2. Influence of Crystallite Size on Lanthanide Ion Photoluminescence Intensity
The effect of the observed increase in crystallite size with annealing on Ln ion luminescence
intensity was next investigated. Hypothesizing that increases in crystallite size would correlate
with increased lanthanide ion emission intensity, photoluminescence excitation and emission spectra
were monitored over time by removing aliquots of Tb:CaF2 NPs at different time points during the
hydrothermal treatment For the Tb-doped CaF2 NPs, changes to the photoluminescent properties were
observed by monitoring the Tb 5D4→ 7F5 transition at 545 nm (Figure 2A,B); corresponding PXRD
measurements were also performed on these aliquots, and crystallite size was estimated from line
broadening (Figure 2C).
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Figure 2. ( ) Excitation spectru of CaF2:Tb Ps with variable hydrother al annealing times,
monitoring the intensity of the 545 nm emission. (B) Emission intensity of the samples when excited
by 320 nm radiation. (C) Crystallite size data estimated from XRD patterns of each sample using the
Scherrer equation. (D) Emission intensity at 545 nm plotted vs. increasing hydrothermal heating time.
The as-prepared CaF2:Tb NPs were observed to be only weakly photoluminescent, having low
initial absorptivity across the 300–400 nm range, and negligible emission intensity in the visible region.
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With increased annealing time, absorptivity initially increased over the wavelength range 300–400 nm.
At longer time points, increased absorptivity extended down to 275 nm (Figure 2A). These increases in
absorptivity were well correlated with increased photoluminescence intensity in the visible region.
For example, the increase in intensity at 545 nm, which was initially significant, is even more dramatic
at longer annealing times as the absorptivity at shorter wavelengths increases (Figure 2B). Both the
excitation and emission spectral changes plateau after 4.5 h.
While the photoelectronic properties are observed to plateau only after 4.5 h, by PXRD line
broadening it was observed that the mean crystallite size no longer increased after 1.5 h of hydrothermal
treatment (Figure 2C); that is, the photoluminescence emission intensity continued to increase while
the crystallite size did not (Figure 2D). The further increase in emission intensity with hydrothermal
heating time (up to 6 h) is most likely the result of the reduction in the concentrations of point defects
within the CaF2 matrices, leading to decreasing probability of non-radiative decay of the nanocrystal
excited state at those sites and increasing probability of radiative decay at Ln-ion dopant sites [31,32].
3.3. Mesoporous Silica Coating and Organosilane Surface Modification
Following successful synthesis of citrate-stabilized CaF2:Ln NPs, a mesoporous silica (MS) coating
was subsequently deposited on the NP surfaces to prepare CaF2:Ln-MS NPs (Figure 3A). This MS
coating was applied for several reasons. First, the as-prepared citrate-stabilized NPs were not easily
redispersed as stable aqueous colloids, thus limiting their biological potential; we hypothesized that
the MS coating would increase the hydrophilicity of the NPs to promote colloidal stability [33]. Further,
the MS coating provides the opportunity to covalently modify the NP surfaces with a wide variety
of commercially available organosilane reagents [34], thus permitting further synthetic alterations to
increase colloidal stability and biological utility. Finally, MS NPs on their own are popular biomedical
formulations due not only to their hydrophilicity, but also to their ability to carry and release an
encapsulated small molecule payload. Mesoporous silica NPs have pores with sizes that are tailorable in
synthesis, and as such, they have been studied as host vehicles in a variety of drug delivery, therapeutic,
and imaging applications as well as non-medical uses such as food active packaging [9,35–37].
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To prepare CaF2:Ln-MS NPs, we modified a literature procedure used in the production of hollow
mesoporous silica NPs, where relatively thin mesoporous silica shells were uniformly deposited onto
solid silica cores that were later removed by selective structural etching [38]. Following deposition
of the MS coating, morphological evaluation of a sample of CaF2:Tb-MS NPs by TEM revealed that
occurrences of multiple CaF2 cores in single MS shells were commonly observed, and that isolated
particles had an overall average diameter of 55 ± 9 nm (Figure 3). Since the overall average diameter
is less than 100 nm, these NP constructs are potentially appropriately sized for use as intravenously
administered agents [39,40]. Further, in high-resolution images (not shown), ~2–3 nm diameter pores
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are observed in the silica shells, and these voids are large enough to enclose a variety of small organic
molecules. EDX analysis of the CaF2:Tb-MS NPs provides the estimate that these structures are ~61%
silica and 36% CaF2:Tb by mass.
While mesoporous silica coatings on NPs are common in literature, applying a silica coating to
a new NP system presents optimization challenges, including avoiding the aggregation of multiple
NPs within single shells and self-nucleation of pure mesoporous silica NPs. While optimization is
beyond the scope of this proof of principle synthesis and functionality assessment, we observed that the
CaF2:TEOS ratio was crucial to control in order to reproducibly coat the CaF2:Tb NPs while maintaining
a significant mass% of CaF2:Tb, which kept the formulation observably luminescent. Of the various
ratios tested, 300 µL of TEOS to 54 mg of CaF2 in a 110 mL water/ethanol system was found to be
optimal for minimizing particle aggregation related to surface charge. Lower concentrations of TEOS
resulted in CaF2 without silica coatings, whereas higher concentrations of TEOS led to NP size increases
due to coating thicknesses that would be prohibitive to cellular uptake or use as an RL agent.
Following silica coating, the CaF2:Tb-MS NPs were covalently functionalized with polyethylene
glycol (PEG) using a PEG-silane precursor and conventional aqueous surface silanization methods.
In general, PEG coatings are known to provide excellent water dispersability for NPs, while also
lowering their zeta potential. The latter is thought to be critical in preventing NP opsonization, which is
the electrostatic aggregation of proteins in biological systems that signals to immune cells that an object
should be eliminated. This PEG coating makes the NPs in this work more applicable to the in vitro
assays used to determine their XRT enhancement capability, however, intravenous applications would
require additional surface modification. Delivery of NPs to tumors through passive accumulation
results in low concentrations of NPs in the tumor tissues [41]. To increase the likelihood of the NP
accumulation in a specific type of lesion, ligands would have to be attached to the surface such that the
NPs were likely to bind to the target tissue’s cell membranes. For in vitro experiments, PEG alone was
used to decrease the zeta potential of the NPs and prevent them from damaging cell membranes upon
contact. As a dense layer of PEG is thought to be more effective in the prevention of NP opsonization,
we employed basic conditions in order to promote complete and rapid hydrolysis of the PEG-silane
precursor on to the CaF2:Tb-MS NP surfaces [42–44].
Briefly, the CaF2:Ln-MS-PEG NPs were synthesized by dispersing the CaF2:Ln-MS NPs in an
aqueous solution containing a catalytic amount of aqueous base, then adding an excess of PEG-silane
and stirring at room temperature. Compared to other combinations of weaker bases and anhydrous
ethanol, ammonium hydroxide in water was found to result in attaching the largest amount of organic
mass to the silica surface (Table S2). An analysis of the conditions of PEG-silane attachment is provided
in the Supporting Information. Following PEGylation, the resulting CaF2:Ln MS-PEG NPs were
collected via centrifugation and cured overnight at 60 ◦C. It has been shown that the addition of a
curing step can aid in the attachment of weakly bound silanes to either the silica surface or to each other
by dehydrating the material, thus encouraging dehydration condensation of the silanol groups on the
silane and silica surface [45]. TEM evaluation indicated no significant morphological changes in the
NPs following the covalent surface grafting with PEG-silane (Figure 3B). Additionally, DLS analysis
revealed that CaF2:Tb-MS-PEG NPs dispersed in millipure water have a mean hydrodynamic diameter
of 299 ± 2 nm, PDI of 0.372 ± 0.016, and a zeta potential of −32.2 ± 0.473 mV. The hydrodynamic
diameter is greater than those observed by TEM imaging, suggesting that the NPs attract a significant
layer of water around them, likely due to the hydrophilicity of PEG [46,47]. The charge at the surface
of the NP is still partially negative, most likely left over from the partial protonation of remaining
silanol groups on the silica surface [48].
The success of surface modification steps was validated by FT-IR spectroscopy, which was used to
confirm the chemical identities of surface species for isolated NP products (Figure 3C). Prior to the
addition of the mesoporous silica coating, the most prominent absorbances in the CaF2:Tb spectrum
result from COO– stretching vibrations, which can be attributed to the citrate used as a stabilizer
during synthesis [49]. After the addition of the silica coating, the Si–O–Si stretch becomes prominent at
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1050 cm−1 (Figure 3C). Lastly, PEGylation of the CaF2:Tb-MS NPs is supported by the presence of new
alkyl C–H stretches at 2900 cm−1, which can be attributed to the sp3 C–H bonds of the ethyl groups in
PEG. Taken together, these findings confirm that the CaF2:Tb-MS-PEG NPs were successfully produced,
and their radiological and biological properties are further examined in the following sections.
3.4. Radioluminescent Properties of CaF2:Ln Nanoparticles (NPs)
Photoluminescent CaF2:Ln NPs have been studied by several groups in the fields of biomedical
diagnostics and therapeutics [20–23], as CaF2:Ln NPs can act as a source of visible-range photons,
similar to other formulations of NP which enable imaging within biological tissues [15,16]. The same
emitted photons can also photocatalyze specific chemical reactions, producing toxic species to kill
local cells in a process commonly known as photodynamic therapy (PDT) [50–52]. One of the most
prominent applications of CaF2:Ln NPs is in two-photon near-IR to visible energy conversion for
deep tissue diagnostic and therapeutic applications. However, X-rays have greater biological tissue
penetration depth as compared to near IR radiation, and consequently, interest in radioluminescence
(RL) applications of CaF2 optical matrices has been stimulated [53].
While bulk CaF2 and Ln-doped CaF2 have been widely explored in RL applications, the RL
characterization of doped CaF2 nanomaterials is less common. The intrinsic RL properties of undoped
CaF2 NPs have been explored by Bezzera et al., who observed emission attributed to self-trapped
excitons at 293 nm and from the F-centers at 428 nm [28]. Comparatively, Jacobsohn et al. investigated
CaF2:Eu NPs, where irradiation with a 40 kV X-ray source resulted in emission intensity at 420 nm,
indicative of the presence of Eu2+, as well as the expected Eu3+ emission transitions between
550–700 nm [54]. These studies illustrate that the RL properties of CaF2 and CaF2:Ln observed on
the bulk scale are preserved in the nanoscale materials, which promoted our interest in exploring the
potential of RL CaF2:Ln NPs in biomedical X-ray imaging and therapeutic applications.
To assess radioluminescence, dry powders of CaF2, CaF2:Tb, and CaF2:Eu were irradiated at
130 kVp using a X-ray irradiator and visible light emission in the 400–800 nm range was monitored using
a fiber-optic spectrophotometer. Each type of NP was assessed with and without the mesoporous silica
shell. Expectantly, the undoped CaF2-MS NPs did not produce visible radioluminescence under these
conditions (Figure S2), as the self-trapped exciton transition of CaF2 emits at too short of a wavelength
to be observed with this RL measurement apparatus. In comparison, the lanthanide-doped CaF2-MS
NPs displayed bright radioluminescence upon X-ray excitation (Figure 4). The CaF2:Eu-MS NPs
exhibited distinct Eu emission peaks at 540 nm (5D1→ 7F2), 590 nm (5D0→ 7F1), 610 nm (5D0→ 7F2),
and 693 nm (5D0→ 7F4), with the 5D0→ 7F2 emission at 590 nm being most intense. Comparatively,
The CaF2:Tb-MS NPs displayed characteristic emission peaks at 490 nm (5D4 → 7F6), 542 nm (5D4
→
7F5), 586 nm (5D4 → 7F4), and 621 nm (5D4 → 7F3), of which the 5D4 → 7F5 transition at 542 nm
displays the highest emission intensity. We compared the RL of these samples to the as-synthesized
CaF2:Ln NPs, without the MS shell, and did not observe any significant spectral differences in the
case of Ln = Tb (Figure S2). However, in the case of Ln = Eu, the MS shell addition increased the
relative intensity of the 5D1→ 7F2 emission, which is perhaps attributable to a change in coordination
environment of surface Ln ions (Figure S2) [55,56]. The relative emission intensities are known to
be informative as to the coordination of the Eu dopant ions within the fluorite crystal structure and
the dominance of the 5D1 → 7F2 transition at 591 nm implies that the dopants are replacing Ca2+
in the lattice [18,19]. Overall, these findings demonstrated the X-ray activation of lanthanide ion
luminescence in the CaF2:Ln-MS NPs, and we further assessed the CaF2:Tb-MS NPs in cyotoxicology
experiments, both in the absence and presence of incident X-radiation.
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3.5. Cytotoxicity Assessment of CaF2:Tb NPs
Following surface modification to prepare water-dispersible CaF2:Tb-MS-PEG NPs, cytotoxicity
towards murine fibroblast (3T3 NIH) and human liver carcinoma (HepG2) was assessed. Here,
cell viability was determined using an alamarBlue spectrophotometric assay, 24 h following exposure
of the cells to the NPs at varying concentrations. As seen in Figure 5, CaF2:Tb-MS-PEG NPs
displayed minimal cytotoxicity towards either cell line, at concentrations ranging from 2–500 µg/mL.
The CaF2:Tb-MS-PEG NPs met our established threshold (>80% viability) for cytocompatibility in
the absence of X-radiation, and the overall low in vitro toxicity renders them promising for in vivo
biological applications.
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3.6. Assessment of CaF2:Tb-MS-PEG NPs for X-ray Radiotherapy Enhancement
In cancer-based applications, CaF2-based biomaterials have been widely investigated as
nanocarriers for therapeutic applications such as gene therapy, chemotherapy, photothermal therapy,
and photodynamic therapy [57]. However, the reliance of some of these applications on excitation
by near-IR photons introduces limitations due to poor tissue penetration by the incident light,
which motivates further study into excitation using X-ray photons that have greater penetration
depth [53]. A promising application that uses X-rays to excite nanomaterials is XRT enhancement,
which has the goal of increasing local radiation damage in the vicinity of cancer-targeted NPs [2,58].
To date, however, only one other study has been published on the design of CaF2 NPs for X-ray
activated therapy. In that work, Zahedifar et al. studied the use of RL CaF2:Tm NPs to excite the
photosensitizer PPIX during X-ray irradiation. The results of this study showed good overlap between
the RL emission of the NPs with the absorption band of PPIX, and indirect measurements of singlet
oxygen generation suggest that the CaF2:Tm NP/PPIX system could be usefully applied under XRT
conditions to enhance ROS generation [59]. Building on the progress of these studies, the following sets
of experiments provide further evidence of CaF2-based NPs in the enhancement of cellular damage
during XRT in vitro. As opposed to NP formulations which rely on singlet oxygen generation via a
photosensitizer, this platform relies only on the conversion of X-ray photons to lower energy photons,
enabled by the dense, crystalline NP.
Here, the ability of the CaF2:Tb-MS-PE Ps to enhance S generation as spectroscopically
assessed using two selective, molecular sensors, hic all a tificati f roxyl radical and
singlet oxygen production as a function of the applie -r r i ti ; tr l sa ples of water
without NPs wer measured under identical conditions ( i , . i i teraction with the
specific reactive speci s, the corresponding molecular sen or (Aminophenyl fluorescein (APF) for OH·
and Singlet Oxyg n Sensor Gr en (SOSG) for 1O2) become highly fluorescent, and th fluorescence
intensity is known to increase in respons to a increase in the concentration of th ROS a aly e [60,61].
In hese solution fluorescence spectroscopy experiments, we observed that upon X-ray irradiation,
the CaF2:Tb-MS-PEG NPs greatly enhanc d the production of hydroxyl radical as compared to the
control solution. For the CaF2:Tb-MS-PEG NPs, the fluorescence intensity linearly increased s the
radiation dose increased (Fig re 6A). The observed increase in hydroxyl formation in the presence
of the CaF2:Tb-MS-PEG NPs with increasing radiation dose is likely due to direct absorption of the
incident energy by the CaF2:Tb NP cores followed by energy deposition via X-ray scattering; some of
these scattered photons would be expected to result in downstream OH· production. However, it is
possible that the incorporation of the silica layer in the CaF2:Tb-MS-PEG NPs may also be contributing
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to the observed increase in hydroxyl radical formation under XRT conditions, which is supported by
prior work [62].
Nanomaterials 2020, 10, x FOR PEER REVIEW 14 of 18 
 
NPs may also be contributing to the observed increase in hydroxyl radical formation under XRT 
conditions, which is supported by prior work [62]. 
Figure 6. Assessment of CaF2:Tb-MS-PEG NPs for XRT. Fluorescent sensor XRT enhancement assays 
as a function of radiation dose for (A) hydroxyl radical using detection of aminophenyl fluorescein 
(APF) fluorescence intensity and (B) singlet oxygen using detection of Singlet Oxygen Sensor Green 
(SOSG) fluorescence intensity, with and without CaF2:Tb-MS-PEG NPs (125 µg/mL). In vitro cell 
viability assay (C) evaluating synergetic effects of XRT (4 Gy) and CaF2:Tb-MS-PEG NPs (0 to 500 
µg/mL) on CT26 colorectal cancer cells; (+)-IR = with irradiation, (-)-IR = without irradiation. 
Comparatively, the incorporation of CaF2:Tb-MS-PEG NPs did not result in any significant 
increase in singlet oxygen generation as compared to the control solution (Figure 6B). These findings 
are unsurprising given that the excitation of dissolved O2 is typically achieved through a 
photosensitizer-mediated mechanism, and no purposeful photosensitizer is included in the present 
NP system. However, it should be noted that while SOSG is commonly used to determine singlet 
oxygen formation in PDT therapy using a UV-light source, it may not be a suitable probe for the 
detection of singlet oxygen in the presence of higher energy radiation. A recent report by Liu et al. 
found that following 320 kVp radiation, SOSG solutions demonstrated increasing fluorescence 
intensity with increasing radiation dose [63], which was found to be independent of singlet oxygen 
formation. These results suggest that the fluorescent probe is directly activated by the incident 
radiation exposure, which correlates well with our observation that the fluorescence intensity of the 
control solution increases somewhat linearly with the incident radiation dose and that the response 
is largely the same with or without NPs present (Figure 6B). Overall, the fluorescent probe XRT assays 
support the ability of the CaF2:Tb-MS-PEG NPs to enhance hydroxyl radical formation using incident 
X-rays, demonstrating them as potential radiosensitizing agents. 
After spectroscopic evaluation of the CaF2:Tb-MS-PEG NPs for enhancing ROS generation under 
X-ray irradiation, cell viability studies were performed to assess their potential to act synergistically 
with XRT in vitro. Here, CaF2:Tb-MS-PEG NPs were incubated with murine CT26 colorectal cells at 
various concentrations (0 to 500 µg/mL) for 24 h, followed by irradiation of the experimental cell 
samples (+-IR) with a 4 Gy radiation dose; the viability of experimental cell samples was compared 
against un-irradiated control cells ((-)-IR). Twenty-four hours after irradiation, cell viability was 
assessed using the alamarBlue assay. This assay measures the metabolic activity of a cell population, 
which can be correlated to the fraction of living cells. As shown in Figure 6C, there is some correlation 
between decreased cell viability and CaF2:Tb-MS-PEG NP concentration, particularly at higher 
concentrations (500–31.3 µg/mL). In the absence of CaF2:Tb-MS-PEG NPs, exposure to ionizing 
radiation resulted in 98% cell viability over the given time frame, demonstrating good 
cytocompatibility of the particles in the absence of X-radiation. Comparatively, exposure and 
incubation with 125 and 500 µg/mL of CaF2:Tb-MS-PEG NPs resulted in decreasing cell viability at 
78% and 68%, respectively. Some conditions led to mean % viabilities above 100%, which may be 
attributed to NPs interacting with cells and possibly increasing their metabolic or proliferative rate 
above that of the control population. 
An important aspect of combination therapies is maximizing the anticancer effects while 
minimizing toxicity to healthy tissues. Given the high biocompatibility in the absence of radiation, 
and preliminary studies showing dose-dependent enhancement of cell kill with radiation, the 
Figure 6. Asse ment of CaF2:Tb-MS-PEG NPs for XRT. Fluorescent sensor XRT enhancement as ays as
a function of radiation dose for (A) hydrox l adical using detection of aminophenyl fluorescein (APF)
fluorescence intensity and (B) si glet oxy en using detection of Singlet Oxygen Sensor Green (SOSG)
fluorescence intensity, with and without CaF2:Tb-MS-PEG NPs (125 µg/mL). In vitro cell viability assay
(C) evaluating s nergetic effects of XRT (4 Gy) and CaF2:Tb-MS-PEG NPs (0 to 500 µg/mL) on CT26
colorectal cancer cells; (+)-IR = with irradiation, (-)-IR = without irradiation.
Comparatively, the incorporation of CaF2:Tb- s id not result in any sign ficant
increas in singlet oxygen generation as compared to the ti (Figure 6B). These findings
are unsurprising iven that the excitation of dis olv 2 i ically achieved through a
photosensitizer-mediated mechanism, and no purposeful phot sensitizer is include in the present NP
system. However, it should be noted that while SOSG is commonly used to determine singlet oxygen
formation in PDT therapy using a UV-light source, it may not be a suitable probe for the detection
of singlet oxygen in the presence of higher energy radiation. A recent report by Liu et al. found
that following 320 kVp radiation, SOSG solutions demonstrated increasing fluorescence intensity
with increasing radiation dose [63], which was found to be independent of singlet oxygen formation.
These results suggest that the fluorescent probe is directly activated by the incident radiation exposure,
which correlates well with our observation that the fluorescence intensity of the control solution
increases somewhat linearly with the incident radiation dose and that the response is largely the
same with or without NPs present (Figure 6B). Overall, the fluorescent probe XRT assays support
the ability of the CaF2:Tb-MS-PEG NPs to enhance hydroxyl radical formation using incident X-rays,
demonstrating them as potential radiosensitizing agents.
After spectroscopic evaluation of the CaF2:Tb-MS-PEG NPs for enhancing ROS generation under
X-ray irradiation, cell viability studies were performed to assess their potential to act synergistically
with XRT in vitro. Here, CaF2:Tb-MS-PEG NPs were incubated with murine CT26 colorectal cells at
various concentrations (0 to 500µg/mL) for 24 h, followed by irradiatio of the experiment l ell samples
(+-IR) wi h a 4 Gy radiati dose; the viability of experimental cell samples was comp red against
un-irradiated control cells ((-)-IR). Twenty-four hours after irradiation, cell viability was assessed using
the alamarBlu assay. This assay measures the metabolic activity of a cell populati n, which can be
correlated to the fraction of living cells. As shown in Figure 6C, there is some correlation between
decreased cell viability and CaF2:Tb-MS-PEG NP concentration, particularly at higher concentrations
(500–31.3 µg/mL). In the absence of CaF2:Tb-MS-PEG NPs, exposure to ionizing radiation resulted in
98% cell viability over the given time frame, demonstrating good cytocompatibility of the particles
in the absence of X-radiation. Comparatively, exposure and incubation with 125 and 500 µg/mL of
CaF2:Tb-MS-PEG NPs resulted in decreasing cell viability at 78% and 68%, respectively. Some conditions
led to mean % viabilities above 100%, which may be attributed to NPs interacting with cells and
possibly increasing their metabolic or proliferative rate above that of the control population.
An important aspect of combination therapies is maximizing the anticancer effects while
minimizing toxicity to healthy tissues. Given the high biocompatibility in the absence of
radiation, and preliminary studies showing dose-dependent enhancement of cell kill with radiation,
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the CaF2:Tb-MS-PEG NPs demonstrate promising characteristic for use as an NP radiotherapeutic
agent. Our further work will optimize the structural (e.g., size), spectral (e.g., absorption/emission
spectral overlaps), and surface chemical features (e.g., targeting ligand display) of CaF2:Ln NPs to
further increase the radiotherapeutic efficacy of this NP system.
4. Conclusions
Overall, this study has presented the synthesis, characterization, and evaluation of CaF2- core
mesoporous silica-shell NPs as X-ray activated materials for radioluminescence and radiotherapy
enhancement applications. The CaF2 and Ln-doped CaF2 NPs were synthesized using an aqueous
coprecipitation method. Hydrothermal annealing was then used to fuse small crystallites and improve
the luminescence intensity of the Ln-doped materials. Surface modifications through mesoporous
silica coating and PEGylation post-core-synthesis resulted in water-stable particles that displayed
excellent cytocompatibility. Characterization of the radioluminescence properties of the Ln doped
CaF2 NPs demonstrated their potential for RL-based applications. Additionally, their potential efficacy
as a radiosensitizing material was demonstrated in vitro with enhanced cell kill, serving as an initial
proof of concept demonstration. This is supported by the observed ability of the CaF2 NPs to enhance
hydroxyl radical formation following X-ray irradiation. Moving forward, overall material efficacy
may be improved by the addition of surface ligands to the NPs for targeted therapy. Additionally,
the luminescence of the CaF2 core could potentially be used to enable X-ray excited photodynamic
therapy, which would have the advantages of the current formulation while providing additional
routes for radical production.
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